February 26, 1996
Gish Biomedical Inc., a manufacturer of medical devices, said net earnings for the second fiscal quarter ended Dec. 31 dropped to $97,800, or 3 cents a share, from $413,100, or 13 cents a share, for the corresponding quarter a year ago. Sales rose 7% to $5.8 million from $5.4 million. First-half net income totaled $14,000, compared with $809,900, or 25 cents a share, for the first six months a year earlier. Sales increased 3% to $11.1 million from $10.8 million.
December 6, 1990
Gish Biomedical Inc.'s stock fell 20% Wednesday after the manufacturer of disposable cardiovascular products said sales for its second quarter ending Dec. 31 would be "closer to $5 million rather than the $5.5 million projected by analysts." Gish's stock, which is traded over-the-counter, closed at $9.875 a share, down $2.50.
August 29, 1995
Gish Biomedical Inc., a medical device company, reported that net income rose 31% in the fiscal year ended June 30 to $1.7 million, or 52 cents a share, from $1.3 million, or 41 cents a share, for the prior year. Sales rose 2% to $21.6 million from $21.1 million. Profit for the fourth quarter declined 8% to $399,000, or 12 cents a share, from $435,000, or 14 cents a share, for the same period a year ago. Sales were down 5% to $5.2 million from $5.5 million.
February 11, 1999 |
Struggling Gish Biomedical Inc. said Wednesday it has cut about 45 employees, about 18% of its staff, over the last seven months and is considering a number of "strategic alternatives." The Irvine company, which designs and produces medical devices, said it made the cuts, which involved mostly assembly workers, after losing two major manufacturing customers. Stiff competition in the cardiovascular products market also brought lower prices, Gish said.
September 12, 1997
Gish Biomedical Inc., a manufacturer of disposable surgical products, incurred a net loss of $1.9 million, or 57 cents a share, for the fiscal year ended June 30, primarily from a $1.8-million fourth-quarter write-off from acquiring certain assets of Creative Medical Development in 1996, and a $90,000 increase in inventory reserves. For the prior year, the company reported net income of $329,000, or 10 cents a share. Sales declined 8% to $21.1 million from $23 million.
February 24, 1996 |
Gish Biomedical Inc. said its plan to purchase a line of patient infusion pumps from Creative Medical Development Inc. of Nevada City, Calif., has been approved by Creative shareholders. Gish, which designs and makes devices used in cardiovascular and orthopedic surgery and oncology, will buy the product line for $2.6 million in cash and stock, said Jeanne Miller, Gish's chief financial officer. The purchase will enable Gish to enter the rapidly growing market for home health care, she said.